Furthermore, the prognostic significance of PIK3R1 underexpression persisted in the overall series (p = 0.0013) and in breast cancer subgroups characterized by ERα + (p = 0.0076), PR + (p = 0.043), ERBB2+ (p = 0.018) and also ERBB2- (p = 0.024). This evidence concerns the gene ESR1 and breast carcinoma.